Author

F. Navarro

Primary ORCID profile (0000-0002-4180-422X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

F. NavarroiD1 paper · Universidad de Jaén

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Assay:organoid / primary culture· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Quintard· 2 shared J.-L. Achard· 2 shared X. Gidrol· 2 shared Y. Fouillet· 2 shared A. Ambroa· 1 shared A. Hagelkrüys· 1 shared A. Leopoldi· 1 shared A. Oliver· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

C. Quintard

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An automated microfluidic platform integrating functional vascularized organoids-on-chip

C. Quintard, G. Jonsson, C. Laporte, C. Bissardon, A. Pitaval, N. Werschler, A. Leopoldi, A. Hagelkrüys, P. Blandin, J.-L. Achard, F. Navarro, Y. Fouillet, J. M. Penninger, X. Gidrol

This paper develops a microfluidic platform to create functional vascular networks around organoids, demonstrating perfusion within spheroids and vascular organoids over 15 days.

Nature Communications · Feb 16, 2024Peer-reviewedBioengineering

Microfluidic device integrating a network of hyper-elastic valves for automated glucose stimulation and insulin secretion collection from a single pancreatic islet

C. Quintard, E. Tubbs, J.-L. Achard, F. Navarro, X. Gidrol, Y. Fouillet

bioRxiv · Dec 24, 2021Bioengineering

In vitro and in vivo efficacy of the combination of colistin and endolysins against clinical strains of Multi-Drug Resistant (MDR) pathogens

L. Blasco, A. Ambroa, R. Trastoy, E. Perez-Nadales, F. Fernandez-Cuenca, J. Torre-Cisneros, J. Oteo-Iglesias, A. Oliver, R. Canton, T. J. Kidd, F. Navarro, E. Miro, A. Pascual, G. Bou, L. Martinez-Martinez, M. Tomas

This study evaluates the in vitro and in vivo efficacy of combining colistin with endolysins ElyA1 and ElyA2 against MDR pathogens, finding that ElyA1 enhances colistin's antimicrobial activity and reduces its MIC.

Scientific Reports · Apr 28, 2020Peer-reviewedMicrobiology